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Helicobacter pylori is a specific gastric pathogen that colonizes the stomach in more than
50% of the world’s human population. Infection with this bacterium can induce several
types of gastric pathology, ranging from chronic gastritis to peptic ulcers and even adeno-
carcinoma. Virulent H. pylori isolates encode components of a type IV secretion system
(T4SS), which form a pilus for the injection of virulence proteins such as CagA into host
target cells.This is accomplished by a specialized adhesin on the pilus surface, the protein
CagL, a putative VirB5 ortholog, which binds to host cell β1 integrin, triggering subsequent
delivery of CagA across the host cell membrane. Like the human extracellularmatrix protein
fibronectin, CagL contains an RGD (Arg-Gly-Asp) motif and is able to trigger intracellular sig-
naling pathways by RGD-dependent binding to integrins. While CagL binding to host cells
is mediated primarily by the RGD motif, we identified an auxiliary binding motif for CagL–
integrin interaction. Here, we report on a surface exposed FEANE (Phe-Glu-Ala-Asn-Glu)
interactionmotif in spatial proximity to the RGD sequence,which enhances the interactions
of CagLwith integrins. It will be referred to as RGDhelper sequence (RHS). Competitive cell
adhesion assays with recombinant wild type CagL and point mutants, competition exper-
iments with synthetic cyclic and linear peptides, and peptide array experiments revealed
amino acids essential for the interaction of the RHS motif with integrins. Infection experi-
ments indicate that the RHSmotif plays a role in the early interaction of H. pylori T4SS with
integrin, to trigger signaling and to inject CagA into host cells.We thus postulate that CagL
is a versatileT4SS surface protein equipped with at least two motifs to promote binding to
integrins, thereby causing aberrant signaling within host cells and facilitating translocation
of CagA into host cells, thus contributing directly to H. pylori pathogenesis.
Keywords: CagL, binding motifs, cortactin, ERK kinase, integrin interaction, α5β1
INTRODUCTION
About 50% of the world’s human population is infected by Heli-
cobacter pylori, a gastric pathogen causing gastritis in all infected
individuals and more severe gastric disease in 10–15% of cases
(Amieva and El-Omar, 2008; Atherton and Blaser, 2009; Polk and
Peek, 2010). H. pylori can infect humans lifelong as the conse-
quence of a highly complex host–pathogen crosstalk, and is an
excellent model system to study bacterially induced epithelial cell
signaling cascades which are of relevance to neoplasia. H. pylori
strains are surprisingly diverse in both their genome sequences and
resulting virulence. Multiple bacterial virulence factors such as the
cag pathogenicity island (PAI), the protein CagA, and the vac-
uolating toxin VacA have been identified. Considerable research
interest worldwide is currently focused on the effector protein
CagA because CagA-positive but not CagA-negative H. pylori
strains are associated with the development of severe gastric dis-
eases. A direct causal link between CagA and carcinogenesis in vivo
was achieved by the generation of transgenicmice expressingCagA
(Ohnishi et al., 2008). The cagPAI has been shown to encode a type
IV secretion system (T4SS) for the delivery of CagA into the cyto-
plasm of host target cells, where CagA is phosphorylated by host
tyrosine kinases (Backert and Meyer, 2006; Mueller et al., 2012).
T4SSs are typically composed of 11 VirB proteins (encoded by
virB1–11) and the so-called coupling protein (VirD4, an NTPase).
TheH.pylori cagPAI contains up to 32 genes encodingorthologs of
all 11 VirB proteins andVirD4 as well as various associated factors
(Backert et al., 2002;Backert andSelbach,2008; Fischer,2011;Tegt-
meyer et al., 2011a). Scanning electron microscopy (SEM) studies
showed that the H. pylori T4SS is induced upon host cell con-
tact and forms pilus-like structures protruding from the bacterial
membrane (Rohde et al., 2003; Kwok et al., 2007).
Various cell surface molecules are required for T4SS function,
suggesting a sophisticated control mechanism by which H. pylori
injects CagA (Wessler and Backert, 2008). The first identified host
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receptor for the T4SS was integrin α5β1, according to a series of
experiments including respective knockout cell lines, gene silenc-
ing RNAs, function-blocking antibodies, and competition studies
(Kwok et al., 2007). The bacterial interaction partner was iden-
tified as CagL, a VirB5 ortholog, and specialized adhesin that
is targeted to the pilus surface, where it binds to integrin α5β1
and mediates receptor-dependent delivery of CagA into gastric
epithelial cells (Backert et al., 2008, 2011). Like fibronectin, an
extracellular matrix protein and natural ligand of integrin α5β1,
CagL contains an arginine–glycine–aspartate (RGD) motif that
was shown to be important for interaction with integrin α5β1
on host cells (Kwok et al., 2007). Binding of CagL during infec-
tion or by incubation with recombinant protein in vitro elicits
downstream signaling like tyrosine kinase activation of several
proteins including EGF-receptor, FAK, and Src (Kwok et al., 2007;
Saha et al., 2010; Tegtmeyer et al., 2010) as well as stimulation of
ERK1/2 MAP kinase (Wiedemann et al., 2012). In line with these
observations, various other structural T4SS proteins have subse-
quently also been demonstrated to bind to β1 integrins in vitro,
including CagA, CagI, and CagY (Jiménez-Soto et al., 2009). In
the same study, mutation of the RGD motif in CagL revealed no
reduction of injected CagA during infection (Jiménez-Soto et al.,
2009). Using mass spectrometry it was further reported that sur-
face exposedCagL associates with two other cagPAI proteins,CagI,
and CagH (Shaffer et al., 2011). All three factors are required for
CagA translocation into host cells. SEManalysis revealed that these
proteins are involved in the formation of T4SS pili. The H. pylori
mutant strainsΔcagI andΔcagL failed to formT4SS pili,while the
ΔcagH mutant revealed a hyperpiliated phenotype and produced
pili that are elongated and thickened as compared to those of the
wild type (WT) bacteria (Shaffer et al., 2011). This suggests that
T4SS pilus dimensions may be regulated by CagH. Taken together,
the above results indicate that CagH, CagI, and CagL are compo-
nents of a T4SS subassembly complex involved in the biogenesis
of pili that interact with integrin α5β1 (Kwok et al., 2007; Shaf-
fer et al., 2011). However, the exact co-operation of the various
integrin-targeting cagPAI proteins is not yet clear and needs to be
investigated.
We recently reported on cell-based in vitro binding studies with
WM-115 andAGS cells revealing that CagL not only interacts with
integrin α5β1, but also with αVβ3 and αVβ5 integrins (Conradi
et al., 2011; Wiedemann et al., 2012). Infection and in vitro bind-
ing studies showed thatCagL induces gastrin expression via a novel
integrin αVβ5-integrin linked kinase signaling complex indepen-
dent of CagA injection (Wiedemann et al., 2012). CagL–integrin
αVβ5 interactions were demonstrated by immunoprecipitation
and Biacore binding studies. In addition, the adhesion of WM-115
cells to immobilized CagL was inhibited by cyclic RGD peptides
with pre-defined conformation, where the sequence was based
on the CagL sequenceAla-Leu-Arg-Gly-Asp-Leu-Ala (ALRGDLA;
Conradi et al., 2011). The application of the so-called spatial
screening approach had previously been applied in the screening
of cyclic RGD peptides and resulted in highly active peptides that
efficiently and selectively inhibit the interaction of extracellular
matrix proteins like vitronectin, fibronectin, and fibrinogen with
the integrins αVβ3, α5β1, and αIIbβ3 in the nanomolar IC50 range
(Gurrath et al., 1992; Pfaff et al., 1994; Haubner et al., 1996, 1997;
Weide et al., 2007). The spatial screening approach makes use of
incorporation of single d-amino acids into cyclic peptides in order
to lock the conformation and to predictably present the amino acid
side chain functional groups in a well-defined manner. d-Amino
acids are known to induce and stabilize discrete turn structures in
linear and, especially, cyclic peptides. Different cyclic RGD pep-
tides with the CagL basic sequence ALRGDLA and a d-amino acid
in different positions were synthesized. The variation of the amino
acid stereochemistry contributes to different backbone structures,
increases the spatial diversity, and provides constrained peptides
with different β- and γ-turns. The structures were evaluated using
NMR and molecular dynamics calculations, and activities of the
different peptides were determined in cell adhesion assays. These
structure–activity relationship studies revealed a β-turn around
Asp-d-Leu-Ala-Arg to be favorable for integrin interactions (Con-
radi et al., 2011). The corresponding cyclopeptides were shown to
inhibit integrin-mediated interactions ofWM-115 cellswithCagL.
In particular, the cyclopeptide-7 [c-(-RGDlA-); Table 3, d-amino
acids are written in small letters] displayed high activity (Conradi
et al., 2011).
In comparison with purified CagLWT, purified CagL mutants
(CagLRAD and CagLRGA) exhibited decreased, but not completely
abolished affinity to integrin α5β1, αVβ3, and αVβ5 in vitro (Kwok
et al., 2007; Conradi et al., 2011; Wiedemann et al., 2012). Other
recent studies indicated that the RGD motif of CagL is certainly
important but not sufficient for triggering cell signaling (Tegt-
meyer et al., 2010; Wiedemann et al., 2012). Taken together,
these data strongly underscore the importance of the RGD motif
for CagL binding (Conradi et al., 2011), but also suggested the
existence of one or more yet unidentified auxiliary motifs that
is/are involved in CagL–integrin interactions. Here we report that
another CagL motif, a FEANE-containing sequence, in proximity
to the RGD motif, participates in binding of CagL to integrins
(thus referred to as RHS) and is able to induce cell binding and
signaling both in vitro and during H. pylori infection of gastric
epithelial cells.
MATERIALS AND METHODS
HUMAN CELL CULTURE AND H. PYLORI STRAINS
The human epithelial melanoma cell line WM-115 (ATCC,Wesel,
Germany; CRL-1675™) is an adherent growing cell line with
continuous integrin expression (mainly integrin α5β1, αVβ3, and
αVβ5) and was cultivated in DMEM medium (PAA,Pasching,Aus-
tria) supplemented with 10% fetal bovine serum and 50μg/ml
gentamicin (PAA, Pasching, Austria). The human gastric adeno-
carcinoma cell line AGS (ATCC CRL-1739™) was cultivated in
RPMI 1640 medium, which was supplemented with 10% fetal calf
serum (Gibco, Paisley,UK). Cells were cultivated at 37˚C and 5.3%
(v/v) CO2 and subcultivated in a ratio of 1:3–1:5 every 2–3 days
at a confluence of 70% to 90%. The H. pylori strains P12 WT and
P12ΔcagL were generated and grown as described (Kwok et al.,
2007). To complement the P12ΔcagL mutant strain, genes encod-
ing CagLWT or CagL mutant proteins were introduced into the
chromosomal ureA locus, using a pAD1-derived plasmid. CagL
proteins expressed from the ureA promoter contain a hemagglu-
tinin (HA) tag introduced following the signal sequence at amino
acid position 22 (Shaffer et al., 2011). For infection,H. pylori were
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grown for 2 days in thin layers and added at a multiplicity of infec-
tion (MOI) of 50 or 100 (Selbach et al., 2002; Moese et al., 2004).
The number of elongated AGS cells in each experiment was quan-
tified in 10 different 0.25mm2 fields (Tegtmeyer et al., 2011b). All
experiments were done in triplicate.
CagL PROTEIN EXPRESSION AND PURIFICATION
CagLWT andmutantswere expressed asC-terminalHis-tag fusions
in vector pET28a (Novagen®, Merck, Darmstadt, Germany) and
purified as described earlier (Kwok et al., 2007). Briefly, E. coli
ER2566 (NEB, Ipswich,USA) transformed with the plasmids were
grown in 10ml LB medium at 37˚C. After overnight incubation,
500ml of fresh LB medium were added and shaken for another
2.5–3 h until reaching OD600 = 1. Then 300μl of a 1-mM IPTG
stock solution was added and the bacteria were grown for 1.5 h
to induce CagL expression. Bacterial pellets were collected by cen-
trifugation and then resuspended in ice-cold buffer CW (50mM
KH2PO4–K2HPO4, pH 7.5, 200mM NaCl) supplemented with
20μM PMSF. After lysis using a French Press, the overexpressed
CagL present in the inclusion bodies was solubilized in buffer LW
(50mM KH2PO4–K2HPO4, pH 7.5, 200mM NaCl, 6M guani-
dine hydrochloride) and refolded by a rapid dilution approach in
ice-cold refolding buffer (50mM Tris–HCl, pH 8.2, 20mM NaCl,
0.1mM KCl, 1mM EDTA, 2mM reduced glutathione, 0.2mM
oxidized glutathione) using a dual-channel syringe pump (KD
Scientific Inc., Holliston, USA) with a flow of 0.1ml/min. After
refolding, CagL was further purified by metal-chelate affinity
chromatography through Talon® resin (BD Biosciences). Protein
concentrations of the resultant samples were determined by Nan-
oDrop 1000 (Thermo Scientific, Waltman, USA) and typically
yielded a total amount of about 1.5mg CagL in 10ml buffer.
Purification of CagL was judged to be of >95% homogeneity by
SDS-PAGE/Coomassie Blue staining. The folded conformation of
the purified CagL proteins was subsequently confirmed by circular
dichroism (CD) as described below.
SITE-DIRECTED MUTAGENESIS
Site-directed mutagenesis of CagL was performed using the corre-
sponding pET28a or pAD1 vectors as DNA template (Table 1). For
amplification, Phusion® High-Fidelity DNA Polymerase (NEB,
Ipswich, USA) was used, followed by PCR purification (MinElute
PCR Purification Kit, Qiagen, Hilden, Germany), digestion with
DpnI (Promega, Madison, USA), and ligation using T4 DNA Lig-
ase (Promega). Re-sequencing and Western blotting of E. coli or
H. pylori strains, respectively, verified the appropriate expression
of CagL in the resulting plasmids.
CELL ADHESION ASSAYS WITH WM-115 CELLS
The cell adhesion assays to immobilized CagL proteins were
performed as described previously (Conradi et al., 2011). A 96
well microtiter plate (Nunc Maxisorp™, Thermo Fisher Scientific
Inc., Waltham, USA) was coated with 100μl of protein solution
(CagLWT or mutant; 10–20μg/ml) per well, and immobilized for
18 h at 37˚C. The solutionwas aspirated and free binding sites were
blockedwith 100μl of a solution,consisting of 2%(w/v) fatty acid-
free BSA (PAA,Pasching,Austria) in PBS for 1 h at 37˚C. The adhe-
sion assays were performedwithWM-115 human epithelial cancer
Table 1 | Primers used for generating the different CagL mutants.
Protein Primers
CagLF86A fw 5′-Pho-GCC GAA GCG AAT GAGTTATTTT
rv 5′-Pho-ATT GGCTTT CAATAA CGCTAA ATC
CagLE87A fw 5′-Pho-GCG AAT GAGTTATTTTTC ATCTCA G
rv 5′-Pho-TGC AAA ATT GGCTTT CAATAA CGCTA
CagLE87A/A88E fw 5′-Pho-GCG AAT GAGTTATTTTTC ATCTCA GAA
rv 5′-Pho-TC AAA ATT GGCTTT CAATAA CGCTAA
CagLN89A fw 5′-Pho-GCT GAGTTATTTTTC ATCTCA GAA
rv 5′-Pho-CGCTTC AAA ATT GGCTTT CAATAA
CagLE90A fw 5′-Pho-GTT ATTTTT CAT CTC AGA AGATGT
rv 5′-Pho-GCATTC GCTTCA AAATTG GC
CagLQ40A fw 5′-Pho-GTG CTC AAA AACTTA GAT GAG ATTTTTTCA
rv 5′-Pho-TGCTTG GTT GGT CTCTTG GTA G
CagLA84E/E87A fw 5′-Pho-TTT GCA GCG AAT GAGTTATTTTTC
rv 5′-Pho-ATT CTCTTT CAATAA CGCTAA ATCTC
CagLA88E/L91A fw 5′-Pho-GAG GCATTTTTC ATCTCA GAA GAT G
rv 5′-Pho-ATT CTCTTC AAA ATT GGCTTT CAA
cells. This cell line was chosen for the cell adhesion assays due to a
constitutive expression of integrin α5β1, αVβ3, and αVβ5, and was
shown to display reproducible adherence to CagL and fibronectin
(Conradi et al., 2011). The WM-115 cells were cultivated to a con-
fluence of 70%, and detached with Trypsin-EDTA (0.05/0.02%
in D-PBS; PAA, Pasching, Austria). After washing with DMEM
medium, the cells were resuspended in DMEM medium with
1mg/ml fluorescein diacetate (Sigma-Aldrich, St. Louis, USA),
adjusted to a cell density of 1× 105 cells/ml and incubated at 37˚C
for 30min under steady shaking. Two DMEM washing steps were
performed to remove excess fluorescein diacetate. The cells were
resuspended in DMEM medium containing divalent cations Ca2+
and Mg2+ (2 nM) to a cell density of 1× 105 cells/ml and incu-
bated in the dark on ice for 30min. Subsequently, the cell solution
was distributed into solutions of peptides ranging in concentra-
tions of millimolar to nanomolar, and the resulting mixtures were
incubated at 37˚C for 30min. The solutions were then dispensed
on the coated microtiter plate (5× 103 cells/well) and incubated
for 1 h at 37˚C. After several washing steps the fluorescence of cells,
adherent to the immobilized CagL, was measured (λex 485 nm;
λem 514 nm) using an Infinite 200 Microplate Reader (Tecan,
Männedorf, Switzerland). The inhibition concentration IC50, con-
fidence interval CI95%, and the square of the correlation coefficient
R2 values were evaluated. To test the accuracy of the fit model for
the non-linear regression a “Runs test” was performed and high
P-values were obtained for all measurements (data not shown),
which support the chosen regression model. All evaluation was
performed using the GraphPad Prism 4.03 Software (GraphPad,
San Diego, USA).
HELICOBACTER PYLORI BINDING TO AGS CELLS
Infection of AGS at a density of 3.2× 105 cells/well was performed
using a MOI of 50 or 100 per H. pylori strain (Kwok et al.,
2002). After infection for 4 h, the AGS-bacterium co-cultures were
washed three times with 1ml of pre-warmed RPMI medium per
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well to removenon-adherent bacteria. Todetermine the total num-
ber of colony forming units (CFU) corresponding to host-bound
H. pylori, the infected monolayers were incubated with 1ml of
0.1% saponin in PBS at 37˚C for 15min. The resulting suspen-
sions were diluted and incubated on GC agar plates as described
(Kwok et al., 2002). The total CFUof cell-boundH. pylori are given
as CFU per well of AGS cells.
CagL PEPTIDE SYNTHESIS
All Fmoc-α-amino acids (9-fluorenylmethylcarbonyl-protectedα-
amino acids) were purchased from IRIS Biotech (Marktredwitz,
Germany) and Advanced ChemTech (Louisville, USA). MALDI-
ToF MS analyses were performed on a Voyager-DE (Perseptive
Biosystems, Foster City, USA) using 2,5-dihydrobenzoic acid as
the matrix. The analytical RP-HPLC was performed with UV
detection at 220 nm and the following elution gradients: elu-
ent A: 95% water, 5% acetonitrile, 0.1% TFA; Eluent B: 95%
acetonitrile, 5% water, 0.1% TFA; 0.7mlmin−1, 0–5min 100%
A→ 100% B; 5–6min 100% B→ 100% A; 6–6.5min 100% A
(Thermo Separation Products apparatus equipped with a Hypersil
Gold (3μm, 150mm× 2.1mm) column (Thermo Fisher Sci-
entific, Waltham, USA). Preparative RP-HPLC was performed
on a Thermo Separation Products apparatus equipped with a
Jupiter C18 (350Å, 10μm, 250mm× 21.2mm) efficiency col-
umn (Phenomenex, Torrance, USA) with water/acetonitrile gra-
dients as the eluent and UV detection at 220 nm. Linear pep-
tides were synthesized by solid phase peptide synthesis on a
Liberty 12 channel microwave-assisted automated peptide syn-
thesizer (CEM, Matthews, USA) according to a Fmoc-protocol
with 2-chlorotrityl resin (IRIS Biotech) as solid support. The resin
loading was 0.8mmol/g. The C-terminal resin bound amino acids
were Phe for cyclopeptides-2 to -5, d-Phe for cyclopeptide-1, and
Val for the linear peptide 6. Peptide coupling was performed
with three equivalents of Fmoc-amino acid (0.5M in DMF),
three equivalents TBTU (3-[bis-(dimethylamino)methyliumyl]-
3H -benzotriazol-1-oxide; 0.5M in DMF; dimethylformamide),
and six equivalents DIPEA [diisopropylethylamine; 2M in
NMP (1-methyl-2-pyrrolidone)]. After washing with DMF the
Fmoc group was cleaved with a solution of 20% piperidine
in DMF. After synthesis of the bound linear peptides, resin
cleavage was performed with 1% TFA (trifluoroacetic acid) in
dichloromethane (10 times for 5min each). The peptides one to
five were cyclized under pseudo-high dilution conditions (Male-
sevic et al., 2004). For slow reagent addition a dual-channel
syringe pump (KD Scientific Inc., Holliston, USA) was used.
200μmol of linear precursor were dissolved in 20ml DMF,
and 600μmol HATU (1-[bis-(dimethylamino) methyliumyl]-
1H -1,2,3-triazolo[4,5-b]pyridine-3-oxide) were dissolved in the
same volume of DMF. Each solutionwas transferred into a syringe,
and both solutions simultaneously were added to a stirred solu-
tion of 1200μmol DIPEA and 20μmol HATU in 10ml DMF at a
rate of 1.00ml/h (Malesevic et al., 2004). Finally, the mixture was
stirred for further 15min, and the solvent was evaporated under
reduced pressure at a temperature below 30˚C. Peptide purifica-
tion was carried out using preparative RP-HPLC. Deprotection of
the cyclic peptides took place in a mixture of TFA (95%), TIS (tri-
isopropylsilane; 2.5%), and water (2.5%), with shaking at room
temperature for 2 h. The solvent was evaporated and cold diethyl
ether (30ml) was added to the residue. After centrifugation for 1 h
at 0˚C and 4000× g, diethyl ether was decanted and the residue
was dissolved inwater, lyophilized, and purified by preparative RP-
HPLC. The yield and purity of the synthesized peptides are given
in Table 2.
CagL PEPTIDE SPOT ARRAYS
The CagL peptide arrays were generated by the SPOT-synthesis
technique as described earlier (Beutling et al., 2008). Briefly, the
indicated peptides in Figure 5 were synthesized on an amino-
functionalized cellulose membrane using Fmoc/tert -butyl chem-
istry. The spots consist of∼5 nmol of each peptide (Dikmans et al.,
2006). For the binding assays, the peptide arrays were blocked
overnight at room temperature with blocking buffer consist-
ing of 2× blocking buffer concentrate (Sigma-Aldrich, St. Louis,
MO/USA) and 5% (w/v) sucrose in TBS-T (0.02M sodium phos-
phate buffer with 0.15M sodium chloride (pH 7), 0.05% Tween
20).Approximately 1μg of purified integrinsα5β1,αVβ3, andαVβ5
(Chemicon-Millipore, Billerica, MA, USA) in blocking buffer was
added to CagL peptide arrays for 4 h at room temperature. Next,
the arrays were washed with a 10-fold volume of TBS-T three
times and then incubated with α-integrin-β1, α-integrin-αv, or
α-integrin-β5 antibodies (Santa Cruz, Santa Cruz, USA). Finally,
a chemiluminescence reaction using the ECL Plus kit (Amer-
sham Pharmacia Biotech, Buckinghamshire, UK) was performed
as described below for Western blotting.
CIRCULAR DICHROISM SPECTROSCOPY
Circular dichroism spectroscopy was performed on a Jasco J-810
spectrometer (Jasco, Groß-Umstadt, Germany). For the CD mea-
surements of the CagL proteins a buffer containing 5mM NaCl
and 10mM Na2HPO4 (pH 7.4) was used. The CagLWT and all
mutants were measured in a 1-mm quartz cuvette, adjusted to a
concentration of 3.9 nM. The secondary structure was evaluated
using the deconvolution function of the Spectra Manager II Soft-
ware (Jasco) based on CDPro structure analysis methods using
Yang’s references (Yang et al., 1986; Sreerama and Woody, 2004).
ANTIBODIES AND WESTERN BLOTTING
Treated/infected cells were harvested in ice-cold PBS contain-
ing 1mM Na3VO4 (Sigma-Aldrich). Western blotting was done
Table 2 | Characteristics of synthesized CagL peptides.
Peptide Sequence Yield (%) Puritya (%)
1 c-(-fEANE-) 13.6 >96
2 c-(-FeANE-) 8.0 >99
3 c-(-FEaNE-) 8.0 >95
4 c-(-FEAnE-) 4.0 >99
5 c-(-FEANe-) 16.8 >99
6 ANFEANELFFISEDV 2.1 >94
aThe purity of each peptide was confirmed by analytical HPLC. d-amino acids are
given in small letters.
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as previously described (Tegtmeyer et al., 2009). Rabbit α-
CagL antiserum was raised against the C-terminal peptide (C-
RSLEQSKRQYLQER)of the protein andwas prepared byBiogenes
(Berlin, Germany). The α-HA-tag antibody (Invitrogen, Darm-
stadt, Germany) was also used to detect tagged CagL. The pan-α-
phospho-tyrosine antibody PY-99 (Santa Cruz) and α-CagA (Aus-
tral Biologicals, San Ramon,CA,USA) were used to investigate the
phosphorylation of CagA. The polyclonal α-phospho-ERK1/2-
PT202/PY-204 antibody was purchased from NEB (Frankfurt,
Germany). The polyclonal α-phospho-Cortactin-PS-405 anti-
body was described recently (Tegtmeyer et al., 2011b). The α-
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody
(SantaCruz) served as loading control in eachWestern blot.As sec-
ondary antibodies, horseradish peroxidase conjugated α-mouse,
α-rabbit, or α-goat polyvalent sheep immunoglobulin were used
and antibody detectionwas performedwith the ECLPlus chemilu-
minescence kit (Amersham Pharmacia Biotech). Band intensities
and corresponding kinase activities were quantitated with the
Lumi-Imager F1 (Roche Diagnostics, Mannheim, Germany).
STATISTICAL ANALYSIS
All data were evaluated using Student t -test with SigmaStat statis-
tical software (version 2.0). Statistical significance was defined by
P ≤ 0.05 (∗) andP ≤ 0.005 (∗∗). All error bars shown in figures and
those quoted following the ± signs represent standard deviation.
RESULTS
SYNTHETIC RHS-CYCLOPEPTIDES INFLUENCE WM-115 CELL ADHESION
TO IMMOBILIZED CagL MUTANTS
Previous studies indicated that the RGD sequence in CagL is
important but not sufficient to trigger host cell receptor binding
and signaling (Kwok et al., 2007; Tegtmeyer et al., 2010; Conradi
et al., 2011; Wiedemann et al., 2012). The recently published 3D
homology model of CagL (Backert et al., 2008) was screened for
other surface exposed amino acid sequences to further explore
the hypothesis that other CagL features besides the RGD sequence
might be important for integrin interactions. Among other pos-
sible motifs that are surface exposed and with an orientation that
is directed to the plausible CagL–integrin interaction site, the
so-called RHS motif in proximity to the RGD motif (Figure 1)
was identified as a candidate for host interaction. A series of five
cyclopeptides comprising theRHS sequencewas designed and syn-
thesized tomimic the exposedmotif inCagL (Figure 1).According
to the spatial screening approach each of the five amino acids
was mutually replaced by its d-configured counterpart to sta-
bilize the overall conformation and increase the spatial peptide
backbone diversity (Tables 2 and 3). None of the cyclopeptides-
1 to -5 inhibited WM-115 cell adhesion to immobilized CagLWT
(IC50> 1mM; Table 3). However, WM-115 cell adhesion to the
mutant CagLRAD was inhibited by cyclopeptide-2 [c-(-FeANE-)]
with an IC50 value in the range of 54–430μM (Table 3). In addi-
tion, cyclopeptides-1 and -2 displayed weak inhibition of WM-115
cell adhesion to the mutant CagLRGA with IC50 values of 43–340
and 30–530μM, respectively. The other cyclopeptides-3 to -5 did
not display any significant effect on theWM-115–CagL interaction
(IC50> 1mM; Table 3).
A LINEAR RHS 15-mer PEPTIDE INTERFERES WITH WM-115 ADHESION
TO THE CagLRAD AND CagLRGA MUTANTS
In addition, cell adhesion assays were performed to investigate
whether the linear peptide 6 (ANFEANELFFISEDV) has effects
on the adhesion of WM-115 cells to immobilized CagLWT and its
RGDmutants CagLRGA andCagLRAD. Linear peptide 6mimics the
RHS motif with the Phe-Glu-Ala-Asn-Glu sequence and its adja-
cent amino acids within the CagL protein sequence (Figure 1).
According to its CD spectrum, it does not adopt a discrete con-
formation in solution (data not shown). While linear peptide 6
did not significantly interfere with CagLWT–WM-115 interaction
in the cell adhesion assay (IC50: >1mM), it exhibited a slight
inhibitory activity on the CagLRAD–WM-115 interaction (IC50:
239μM; CI95%: 164–346μM; R2: 0.88) and the CagLRGA–WM-
115 interaction with an IC50 of 9μM (CI95%: 6–15μM; R2: 0.76;
Figure 2; Table 3). In comparison to the properties of the ear-
lier mentioned c-(-RGDlA-) peptide to inhibit the WM-115 cell
adhesion to CagLWT (IC50: 2.31μM; CI95%: 1.40–3.82μM; R2:
0.89) and its RGD mutants CagLRGA (IC50: 1.63μM; CI95%: 1.01–
2.63μM; R2: 0.93) and CagLRAD (IC50: 0.91μM; CI95%: 0.58–
1.43μM; R2: 0.94), the inhibition properties of the linear peptide
6 are obviously reduced (Table 3). Nonetheless the results support
involvement of the RHS motif in CagL–WM-115 interaction.
THE RECOMBINANT CagL MUTANTS ARE CORRECTLY FOLDED
For further investigation of the RHS motif and to reveal the rele-
vance of specific amino acids in this sequence,CagL point mutants
were recombinantly produced in E. coli, where individual amino
acids were replaced by alanine residues (Table 4). CD spectroscopy
was used to verify the correct folding of the mutants CagLF86A,
CagLE87A,CagLE87A/A88E,andCagLE90A in comparison toCagLWT.
The secondary structure composition calculated for CagLWT is in
good accordance with the proposed CagL homology model (Back-
ert et al., 2008) and displays a high content of α-helices (∼35%),
accompanied by β-strands (∼29%, Figure 3A). The mutants
CagLF86A, CagLE87A, CagLE87A/A88E, and CagLE90A CD spectra
display comparable curve shapes like the CagLWT (Figure 3D).
Unfortunately, the amount of CagLN89A protein necessary to esti-
mate the secondary structure and to validate the correct protein
folding with CD spectroscopy could not be obtained and, there-
fore, could not be included in the study. However, to obtain
information on the structural stability and to further compare
the CagLE87A and CagLE90A mutants with CagLWT, temperature-
interval dependent CD measurements were performed ranging
from 0 to 60˚C (Figures 3A–C). In general, all tested proteins
behaved in similar manner, exhibiting temperature-dependent
denaturation above 40˚C. Below 40˚C, the secondary structures
are comparable, with only minor structural differences. In com-
parison, theCagLE90A CDspectrumshowsmaximumdeviations at
temperatures below 20˚C (Figure 3C). In addition, we performed
a pH screening by measuring the CD spectra of CagLWT over a pH
range from four to nine in phosphate buffer and could show that
the protein is very stable under the tested conditions (Figure 3E).
WM-115 CELL ADHESION STUDIES WITH CagL RHS MUTANTS
Different CagL mutants with amino acid variations in the RHS
motif (CagLF86A, CagLE87A, and CagLE90A) were immobilized
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FIGURE 1 | Computational 3D-structure model of CagLWT with
highlighted motifs of interest.The ribbon diagram of CagL shown in this
figure consists of three major helices and a globular domain with the exposed
RGD motif highlighted in the front. The second highlighted FEANE sequence
(here called RHS motif) is shown in a flexible loop, also exposed at the
surface. The CagL homology model is derived from the VirB5 orthologTraC
protein (PDB: 1R8I) encoded in plasmid pKM101 (Yeo et al., 2003; Backert
et al., 2008).
and investigated in cell adhesion assays. The WM-115 cells were
pre-incubated with the previously described cyclopeptide-7 [c-(-
Arg-Gly-Asp-d-Leu-Ala-)] in different concentrations fromnano-
to millimolar ranges to block the RGD-binding site of the inte-
grins. The dose–response curves obtained in these assays are
shown in Figure 4. For comparison, the cell adhesion results of
the recently published CagLWT, CagLRGA, and CagLRAD mutants
are also given in Table 4 (Conradi et al., 2011). Additionally, the
CagLQ40A mutant was included as a negative control to exclude
the possibility that genetic mutations in the CagL sequence may
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Table 3 | Inhibition ofWM-115 cell adhesion to CagL by synthetic peptidesa.
Peptide CagLWT IC50 CagLRGA IC50 CagLRAD IC50
(CI95%); R2 (CI95%); R2 (CI95%); R2
1 c-(-fEANE-) >1mM 43–340μM >1mM
2 c-(-FeANE-) >1mM 30–530μM 54–430μM
3 c-(-FEaNE-) >1mM >1mM >1mM
4 c-(-FEAnE-) >1mM >1mM >1mM
5 c-(-FEANe-) >1mM >1mM >1mM
6 ANFEANELFFISEDV >1mM 9 (6–15)μM; 0.76 239 (164–346)μM; 0.88
7 c-(-RGDlA-) 2.31 (1.40–3.82)μM; 0.89 1.63 (1.01–2.63)μM; 0.93 0.91 (0.58–1.43)μM; 0.94
aThe IC50 values of cyclic peptides one to five are given in ranges, due to weak inhibition properties giving fluctuating results. d-Amino acids are given in small letters.
CI95%, confidence interval; R2, squared correlation coefficient.
FIGURE 2 | Dose–response curve of a linear RHS motif-containing
peptide, inhibiting binding ofWM-115 cells to immobilized CagLWT and
mutants.TheWM-115 cells were pre-incubated in different concentrations
of the linear 15-mer peptide ANFEANELFFISEDV, which mimics the
exposed RHS motif of CagL. Purified CagLWT and the CagLRAD and CagLRGA
mutants were immobilized on plastic surface followed by addition of the
WM-115 cells. After 1 h of co-incubation, the amounts of attached cells
were determined. The data were evaluated using non-linear fit for the
evaluation of the potency of peptide ANFEANELFFISEDV to inhibit the
binding ofWM-115 cells to immobilized CagL.
generally lead to loss of function. Cyclopeptide-7 inhibited WM-
115 cell adhesion to CagLQ40A with an IC50 value of 1.65μM
(CI95% = 1.06–2.55; R2 = 0.92), while the cell adhesion of WM-
115 cells to immobilized CagLF86A was inhibited with an IC50
value of 2.39μM (CI95% = 1.87–3.04μM; R2 = 0.91), a value that
is very similar to that of CagLWT (IC50 = 2.31μM; CI95% = 1.87–
3.04μM; R2 = 0.91). Interesting results were observed in the inhi-
bition assays for themutantsCagLE87A andCagLE90A.WM-115 cell
adhesion to immobilized CagLE87A was inhibited by cyclopeptide-
7 with an IC50 of 0.67μM (CI95% = 0.38–1.18μM; R2 = 0.72),
the lowest value observed for all CagL mutants investigated
(Figure 4; Table 4). The IC50 value of 0.88μM (CI95% = 0.58–
1.35μM; R2 = 0.80) for the inhibition of WM-115 cell adhesion
to immobilized CagLE90A by cyclopeptide-7 is similar, and is
Table 4 | Inhibition ofWM-115 cell adhesion to CagL mutants by
c-(-RGDlA-)a.
Proteina c-(-Arg-Gly-Asp-d-Leu-Ala-) peptide IC50 (CI95%); R2
CagLWT 2.31 (1.40–3.82) μM; 0.89
CagLRAD 1.63 (1.01–2.63) μM; 0.93
CagLRGA 0.91 (0.58–1.43) μM; 0.94
CagLF86A 2.39 (1.87–3.04) μM; 0.91
CagLE87A 0.67 (0.38–1.18) μM; 0.72
CagLE87A/A88E No integrin affinity observed
CagLN89A No data for evaluation
CagLE90A 0.88 (0.58–1.35) μM; 0.80
CagLQ40A 1.65 (1.06–2.55) μM; 0.92
aMeasurements of peptide c-(-RGDlA-) for CagLE87A and CagLE90A proteins exhibit
decreased IC50 values, indicating an integrin affinity loss for both CagL mutants.
d-Amino acids are given in small letters. CI95%, confidence interval; R2, squared
correlation coefficient.
also comparable to the values observed for CagLRGA (0.91μM;
Figure 4; Table 4). In an additional experiment we tested the
doublemutantCagLE87A/A88E to revealmore details on the involve-
ment of CagL amino acid Glu87 in the interaction with WM-115
cells. The double mutant CagLE87A/A88E formally is characterized
by the shift of an acidic amino acid side chain from position 87 to
position 88. The immobilized CagLE87A/A88E protein displayed no
binding to theWM-115 cells, which may indicate a loss of integrin
affinity. In conclusion, the results show remarkably reduced adhe-
sion of WM-115 cells to immobilized CagLE87A and CagLE90A
compared to the CagLWT, which implies a participation of the
glutamates in the CagL–WM-115 interaction.
PEPTIDE ARRAY MAPPING OF THE CagL RHS MOTIF FOR INTEGRIN
BINDING
The previously described SPOT technique (Frank, 2002) was
applied to identify the CagL amino acid sequence responsible
for binding to integrin α5β1. Overlapping linear 15-mer peptides
derived from the CagL sequence from amino acid position 60–
104 were chemically synthesized on a cellulose membrane by the
SPOT method (Frank, 1992). As shown in Figure 5A, adjacent
peptides share the same sequence of 12 amino acids but differ
by three amino acids at the C- or N-terminal ends, respectively.
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FIGURE 3 | Structural evaluation of purified CagL proteins with CD
spectroscopy. (A)The CagLWT secondary structure was evaluated as
described previously (Yang et al., 1986). (A–C)The temperature-dependent
structure stability of the mutants CagLE87A, CagLE90A, and the CagLWT protein
was evaluated in CD measurements. (D) Secondary structure of CagLWT and
mutants CagLF86A, CagLE87A, CagLE87A/A88E, and CagLE90A were evaluated to
control correct folding of the proteins after expression and purification. (E) pH
stability of CagLWT in the pH range four to nine.
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FIGURE 4 | Dose–response curves showing the inhibitory effect of
cyclic RGD peptides onWM-115 cell binding to the different
immobilized CagL proteins in competitive cell adhesion assays.The
purified CagLQ40A, CagLF86A, CagLE87A, and CagLE90A mutant proteins were
immobilized on plastic surface.WM-115 cells were pre-incubated with
varying concentrations of cyclic peptide c-(-RGDlA-; d-amino acids in small
letter), which is known to inhibit WM-115 cell binding to immobilized CagL
in the low μM range (Conradi et al., 2011). Subsequently, theWM-115 cells
were incubated with the immobilized CagL mutants. The amount of
WM-115 cells bound to immobilized CagL was quantified, and the resulting
dose–response curves were evaluated with a non-linear fit to determine the
binding inhibition potency of peptide c-(-RGDlA-) for the interaction of
WM-115 cells with immobilized CagL.
Purified integrin α5β1 was incubated with these membranes and
the binding was assayed as described in the Section “Materials and
Methods.” Figure 5B shows that integrin α5β1 binds to the RGD
motif-containing arraypeptides-3 and -4. In addition,a very strong
signal for arraypeptide-9 covering the RHS motif was recorded
(Figure 5B, top and Figure 5C). Interestingly, two other FEANE
sequence-containing array peptides (-7 and -8) did not bind inte-
grin α5β1, suggesting that the flanking C-terminal sequences are
also important for this interaction. As a control, incubation of the
membranes with two other integrins, αVβ3 and αVβ5 also revealed
signals for the two RGD containing CagL peptides and some weak
signals for arraypeptides-10 or -11, respectively (Figure 5B,middle
and Figure 5C). The mock control blot revealed no signals as
expected (Figure 5B, bottom).
GENERATION OF RHS POINT MUTATIONS OF CagL IN H. PYLORI
To investigate the importance of the RHS motif in CagL directly
during infection with H. pylori, two CagL mutants were generated
carrying the A84E/E87A and A88E/L91A point mutations. Based
on the above described peptide array the two point mutants were
constructed to contain one mutation in the RHS sequence and one
either N- or C-terminal, to cover additional amino acids that may
be relevant for host cell interactions. CagLWT and both mutants
were chromosomally integrated into a P12ΔcagL deletion mutant
and expressed as HA-tag fusions in the ureA locus as described
(Shaffer et al., 2011). The correct expression of each of these CagL
variants was verified by Western blotting using an α-HA antibody
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FIGURE 5 | Mapping of the RHS motif and flanking CagL sequences in
binding to integrins using a peptide array. (A)The design of the array of
15-mer peptides and corresponding CagL amino acid sequences from
position 60–104 is shown. The RGD and RHS motifs are highlighted with
color. (B) Purified integrins α5β1, αVβ3, and αVβ5 were incubated with these
membranes and bound proteins were identified using antibodies as
described in Materials and Methods. As a mock control, buffer-treated
membranes followed by incubation with an integrin-β1 antibody revealed no
signals, as expected. (C) Densitometric measurement of individual spot
intensities using the Lumi-Imager F1 (Roche) revealed the relative amount
of bound binding partner per given peptide in%.The strongest spot
intensity seen was set as 100%.
pylori strains for 4 h, followed by analysis of viable bacterial bind-
ing to cells, as described in Materials and methods. The results
show that each of these strains bound to AGS cells with high effi-
ciency. Some minor differences in binding were seen among the
different strains but were not statistically significant (Figure 6B).
This suggests that mutation of the RHS motif in CagL has no sig-
nificant inhibitory impact on the overall capacity of the bacteria
to bind to AGS host cells.
MUTATION OF THE RHS MOTIF INHIBITS CagA PHOSPHORYLATION AT
EARLY TIMES OF INFECTION
AGS cells were infected with the different complemented H. pylori
strains during a time course of 2 and 4 h, respectively, to investigate
whether strains expressing CagL mutant proteins can trigger the
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injection and phosphorylation of CagA. The results of the α-
phospho-tyrosine and α-CagA specific Western blots show that
P12ΔcagL re-expressing CagLWT can efficiently inject and phos-
phorylate CagA in a time-dependent fashion (Figures 7A,B).
Infection of AGS with P12ΔcagL expressing the CagLA84E/E87A
mutant revealed a ∼46% reduced phospho-CagA signal at 2 h,

























































































FIGURE 6 | Effect of CagL deletion or point mutations in the CagL RHS
motif on binding of H. pylori to AGS cells. (A) A ΔcagL deletion mutant
in strain P12 was generated by replacing the cagL gene with an aphA3
cassette. CagLWT and two CagL mutants carrying either the A84E/E87A or
A88E/L91A point mutations were expressed as HA-tag fusion proteins from
genes integrated into the ureA locus of the P12ΔcagL strain. The correct
expression of each of these CagL variants was verified byWestern blotting
using an α-HA antibody. The α-CagAWestern blot was performed as loading
control. (B) AGS cells were infected with each of these strains for 4 h using
MOI=100, followed by determination of the amount of viable bound H.
pylori per input strain.The quantification data indicate that each of these
strains bound to AGS cells equally well with high efficiency. No significant
differences in results were seen when MOI=50 was used (data not
shown).
4-h time point with almost no difference as compared to the
complemented CagLWT control (Figures 7A,B). This suggests
that mutation of A84E/E87A in CagL affects the injection and
phosphorylation of CagA at very early times of infection. In con-
trast, infectionwith H. pylori expressing the CagLA88E/L91A mutant
revealed a stronger reduction of phospho-CagA signals (∼69%)
at 2 h as compared to the complemented CagLWT control, while
this low level of phospho-CagA did only slightly increase after
4 h of infection (Figures 7A,B). This result shows that a strain
expressing the CagLA88E/L91A mutant protein has a significant
defect in injection and phosphorylation of CagA at both time
points of infection.
MUTATION OF THE RHS MOTIF EXHIBITS SIGNIFICANT SIGNALING
DEFECTS IN H. PYLORI -INDUCED ERK1/2 ACTIVATION
Finally the various RHS mutations in CagL were inspected in
relation to impacts on cellular downstream signaling involved
in the H. pylori-induced AGS cell elongation phenotype. It was
recently shown that besides CagA phosphorylation, the activation
of the ERK1/2 MAP kinase pathway either by H. pylori infection
(Mimuro et al., 2002; Tegtmeyer et al., 2009) or by transfection
CagA in the absence of H. pylori (Higashi et al., 2004) is also cru-
cial for phenotypical outcome. Therefore, we tested whether the
different CagL-expressing H. pylori strains induced the activation
of ERK1/2, using the same conditions as described for Figure 7.
The results of the α-phospho-ERK1/2 Western blots show that
P12 WT or P12ΔcagL re-expressing CagLWT (but not P12ΔcagL)
can efficiently activate this MAP kinase in a time-dependent fash-
ion (Figures 8A,B). Infection of AGS with H. pylori expressing
the complemented CagLA84E/E87A mutant revealed a significantly
(46%) reduced phospho-ERK1/2 signal at 2 h, and a similarly
reduced (38%) phospho-ERK1/2 signal at 4 h time point as com-
pared to the complemented CagLWT control (Figures 8A,B). This
suggests that mutation of A84E/E87A in CagL downregulates not
only the injection and phosphorylation of CagA, but also reduced
the activation of ERK1/2. In addition, infection with H. pylori
expressing the CagLA88E/L91A mutant revealed an even stronger
reduction of phospho-ERK1/2 signals by about 63 or 70% at the
2- or 4-h time points, respectively. This result indicates that the
CagLA88E/L91A mutant has a significantly pronounced defect in
activating ERK1/2 during infection.
MUTATION OF THE RHS MOTIF RESULTS IN REDUCED CORTACTIN
SERINE PHOSPHORYLATION AND AGS CELL ELONGATION
Very recently, we demonstrated that one important downstream
target of activated ERK1/2 during infection is the actin-binding
protein cortactin, phosphorylated at serine residue 405 (Tegt-
meyer et al., 2011b). Hence it was tested whether the various
CagL-expressing strains induce the phosphorylation of cortactin
at S-405 during a time course of 2 and 4 h infection. The results
of the α-phospho-cortactinWestern blots show that P12ΔcagL re-
expressing CagLWT but not P12ΔcagL can efficiently phosphory-
late cortactin in a time-dependent manner (Figures 8A,B). Infec-
tion of AGS cells with H. pylori expressing either CagLA84E/E87A
or CagLA88E/L917A mutants revealed the induction of phospho-
cortactin signals similar to that of CagLWT with no signifi-
cant difference at 2 h, but a strongly reduced (about 45–46%)
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FIGURE 7 | Effects of CagL point mutations in the RHS motif on
CagA injection and phosphorylation during H. pylori infection of
AGS cells. (A)The P12ΔcagL deletion mutant was complemented with
CagLWT or various CagL point mutants. AGS cells were infected with the
different indicated H. pylori strains (MOI=100) during a time course of 2
or 4 h, respectively. The resulting protein lysates were subjected to
Western blotting using α-phospho-tyrosine (PY-99) and α-CagA
antibodies. The α-GAPDH blot served as loading control in each sample.
(B) Quantification of CagA phosphorylation. Densitometric measurement
of individual band intensities of the α-CagA and α-phospho-tyrosine
(PY-99) blots in (A) was performed with the Lumi-Imager F1 (Roche).
Quantification revealed the relative amount of phospho-CagA per sample
in %. Similar inhibitory activities of all mutants were seen when
MOI=50 was used (not shown).
phospho-cortactin signal at the 4-h time point (Figures 8A,B).
This suggests that mutation of CagL in the RHS motif (either
A84E/E87A or A88E/L91A mutations) downregulates cortactin’s
serine phosphorylation to a similar high extent at the 4-h
time point, indicating that the CagLA84E/E87A and CagLA88E/L91A
mutants share a significantly pronounced defect in activating cor-
tactin during infection. Finally, the elongation phenotype was
monitored in the same set of experiments. As shown in Figure 8C,
mutation of the RHS motif at A84E/E87A or A88E/L91A inhib-
ited the elongation phenotype by more than 50% at the 2-h time
point. At the 4-h time point, the CagLA84E/E87A mutant exhibited a
∼20% reduction and the CagLA88E/L91A mutant revealed a ∼43%
reduction as compared to the complemented CagLWT control.
This set of experiments reveals that mutation of the RHS motif in
H. pylori results in significant defects in signaling to cortactin and
cell elongation, especially at very early times of infection.
DISCUSSION
Our previous studies have suggested that the RGD sequence is an
important structural motif in the H. pylori CagL pilus protein,
able to trigger T4SS-mediated host cell binding and signaling, but
this sequence alone is not sufficient (Kwok et al., 2007; Tegtmeyer
et al., 2010; Conradi et al., 2011;Wiedemann et al., 2012). Thus,we
examined the 3D structural CagL model (Backert et al., 2008) to
identify other potential surface exposed CagL–integrin interaction
motifs. In this study, we report on the discovery of a novel motif
in CagL, called RHS consisting of a Phe-Glu-Ala-Asn-Glu core
sequence, which also plays a role in the interaction with host cell
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FIGURE 8 | Mutation of CagL in specific amino acids within the RHS
motif results in defects in H. pylori -triggered ERK1/2 activation,
cortactin phosphorylation, and AGS cell elongation. (A) AGS cells
were infected with the different complemented H. pylori strains
(MOI=100) during a time course of 2 or 4 h, respectively. The same
protein lysates as shown in Figure 7 were subjected toWestern blotting
using the indicated α-phospho-ERK1/2 and α-phospho-cortactin antibodies.
(B) Densitometric measurement of individual band intensities of the blots
in (A) and comparison to total α-ERK1/2 and α-cortactin blots (not shown)
was performed with the Lumi-Imager F1 (Roche). The relative amounts of
phospho-ERK1/2 and phospho-cortactin per sample were quantified and
given in%. (C) Quantification of the AGS cell elongation phenotype in the
same set of experiments. Similar inhibitory activities of all mutants were
seen when MOI=50 was used (not shown).
integrins. A peptide array of overlapping 15-mer peptides derived
from the CagL primary structure showed that peptides contain-
ing the RHS motif of CagL can bind particularly to integrin α5β1,
whereas they bind only weakly to other integrins, such as αVβ3
and αVβ5. Further studies, including the use of CagL-derived pep-
tides in competitive WM-115 cell binding assays, and the analysis
of recombinant CagL point mutants in cell binding in vitro and
during infection of AGS cells with H. pylori, collectively indicated
that the RHS sequence plays an important role in the interaction
of CagL with host cells.
The spatial screening approach (Haubner et al., 1996; Weide
et al., 2007) was employed with five conformationally designed
synthesized cyclopeptides-1 to -5, wherein each of the five amino
acids was mutually replaced by its d-configured correlate to mimic
the RHS sequence of CagL. Receptor binding of such cyclopep-
tides is regarded to be entropically favored, if the receptor-bound
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conformation is still accessible. However, neither the linear RHS-
peptide 6 (ANFEANELFFISEDV) nor the RHS-cyclopeptides-1
to -5 showed a significant effect on WM-115 cell adhesion to
immobilized CagLWT. In contrast, RGD-dependent WM-115 cell
adhesion could be efficiently influenced by the RGD-cyclopeptide-
7. Mutations within the RGD sequence in extracellular matrix
proteins such as fibronectin are usually accompanied by loss of
integrin affinity (Giancotti and Ruoslahti, 1999; Takahashi et al.,
2007; Leiss et al., 2008). This seems not to be fully applicable
to CagL, as integrin-expressing WM-115 cells still adhere to the
mutated proteins CagLRAD and CagLRGA but with reduced affinity
(Conradi et al., 2011). Interestingly, both the linear RHS-peptide
ANFEANELFFISEDV and the RHS-cyclopeptide-2 were able to
interfere with WM-115 cell adhesion to immobilized CagLRGA
and CagLRAD proteins with IC50 values in the micromolar range,
indicating significant binding. The studies with the CagLRGA and
CagLRAD mutants allowedus to distinguishRGD-dependent inter-
action from other types of binding. Not all RHS-cyclopeptides
displayed such inhibitory biological activity, which clearly proves
the influence of peptide conformation and three-dimensional
structure on the anti-adhesive properties. We thus conclude that
the WM-115 cell adhesion to recombinant CagL is mainly driven
by the RGD recognition sequence, but is significantly assisted by
the RHS sequence as a proposed auxiliary motif. There is an inter-
esting analogy to fibronectin. Besides the RGD motif, fibronectin
harbors another sequence required for maximum binding affinity
to integrin α5β1, called the synergy region, located in the ninth
type III module adjacent to the RGD site (Nagai et al., 1991; Aota
et al., 1994; Bowditch et al., 1994; Chada et al., 2006). Subsequent
studies showed that the synergy region is not directly in contact
with the integrinα5β1 bound to fibronectin, and proposed an indi-
rect function of the synergy region for the high affinity binding
by optimally exposing the flexible RGD motif or by inducing long
range electrostatic steering (Baron et al., 1992; Takagi et al., 2003).
In the case of CagL, however, a FEANE-containing peptide alone
can bind integrin α5β1 as shown in peptide arrays, and the synergy
region of fibronectin shares no sequence homology to CagL or the
RHS domain.
The role of the RHS motif and neighboring amino acids
was further investigated on the protein level with recombinant
CagL proteins carrying corresponding point mutants. The sec-
ondary structure and temperature stability of all generated point
mutants corresponds with that observed for CagLWT according
to CD spectra. Given the above assumptions, pre-incubation of
the WM-115 cells with the RGD-cyclopeptide-7 should provide
information on the contribution of the RHS sequence to CagL
binding phenomena. Strikingly, there is an effect of mutations
in the RHS motif of CagL on WM-115 cell adhesion. RGD-
cyclopeptide-7 was able to inhibit cell adhesion to CagL with
mutations in the RHS sequence (CagLF86A, CagLE87A, CagLE90A)
even at lower concentrations than for CagLWT. Granted that cell
adhesion is governed by both RGD and RHS sequences, a muta-
tion in the CagL RGD sequence (CagLRGA, CagLRAD) would lead
to reduced cell adhesion and, hence, require a smaller concen-
tration (reduced IC50) of the RGD-peptide that competes for
binding (Table 4; Conradi et al., 2011). Conversely, WM-115
cell adhesion to immobilized CagL with mutations in the RHS
motif conferring decreased affinity could be inhibited by the
RGD-peptide at a smaller concentration (reduced IC50). This
was indeed observed for CagLE87A and CagLE90A. In conclu-
sion, the point mutant CagLF86A and a control mutant CagLQ40A
show no significant affinity loss in their binding to WM-115
cells as compared to CagLWT, while the point mutants CagLE87A
and CagLE90A display remarkably reduced affinity to WM-115
cells. The replacement of the negatively charged glutamates E87
and E90 by the hydrophobic amino acid alanine resulted in a
decreased affinity toward WM-115 cells. In contrast, the exchange
of the uncharged amino acids phenylalanine F86 and gluta-
mine Q40 by alanine did not have any consequence in the same
assays. These data imply that especially glutamate E87 is impor-
tant for the interaction with integrin on the surface of host
cells.
At first sight, the peptide array experiments in which we inves-
tigated the binding of immobilized CagL 15-mer peptides with the
different purified integrins seem to implicate a stronger signal of a
RHS containing peptide for bound integrinα5β1,butmuchweaker
signals compared to RGD containing peptides on the same mem-
brane. Regarding the conformation of RGD containing peptides,
cyclic RGDpeptides with a β-turn aroundAsp-d-Leu-Ala-Arg dis-
play a much higher affinity to some integrins than do linear RGD
peptides. The linear RGD containing peptides do not prefer this
structural β-turn conformation, which could explain the fact that
linear RGD peptides on the peptide array display very little affin-
ity to integrins as compared to their cyclopeptide counterparts.
While the arraypeptides-7 to -9 contain the whole FEANE amino
acids of the RHS motif, only arraypeptide-9 reveals integrin β1
interaction (Figure 5). In arraypeptide-10 and -11 the 15-mer
peptide sequence is shifted C-terminally for three amino acids.
Arraypeptide-10 therefore is lacking the phenylalanine of the RHS
motif and displays a different interaction with integrin subunit
β3, while the arraypeptide-11 includes only the final glutamate
of the RHS motif and displays weak interaction with the inte-
grin β5 subunit. In cell binding studies with the 15-mer peptide of
arraypeptide-9 corresponding to linear peptide 6, a binding inhibi-
tion ofWM-115 cells to immobilizedCagLRAD andCagLRGA could
be shown (Tables 2 and 3). Overall the binding potency of this lin-
ear peptidewas surprisingly better than that observed for the cyclic
RHS peptides. These results emphasize the possible involvement
of adjacent amino acids next to the FEANE sequence for integrin
interactions that probably are located in the C-terminal flanking
site. The presented results allow no complete elucidation of amino
acids important for integrin interaction, but combining the results
of cell binding studies and the peptide array, the CagL F86 amino
acid is not involved in the interaction withWM-115 cells (Table 3)
and the interaction with purified integrins (Figure 5), while both
glutamates E87 and E90 have an impact and are probably exposed
on the CagL surface. The observed binding of three different inte-
grins to a relatively small CagL sequence region of about 18 amino
acids on peptide arrays is a very interesting finding, and is relevant
to recent reports which showed that CagL interacts not only with
integrin α5β1 on cells, but also αVβ3 and αVβ5 (Kwok et al., 2007;
Conradi et al., 2011; Wiedemann et al., 2012).
Finally, it was investigated if the newly discovered RHS motif
in CagL might also play a role during infections with H. pylori.
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As discussed above, an explicit amino acid region for the so-
called RHS motif could not be clearly defined. Therefore two
double point mutants CagLA84E/E87A and CagLA88E/L91A were cho-
sen, with one mutation in the RHS region and another located
at the N- or C-terminus, respectively. Based on infection exper-
iments, we could show that H. pylori P12 WT, deletion mutant
P12ΔcagL, and P12ΔcagL re-expressing CagLWT or CagL point
mutants (A84E/E87A and A88E/L91A) bound equally well to cul-
tured AGS cells. This suggests that CagL is not involved in general
host cell binding during infection, in agreement with previous
reports showing the overall importance of the major canonical
adhesins BabA/B, SabA, AlpA/B, or OipA (for review, see Tegt-
meyer et al., 2011a). However, this illustrates clearly that the
observed signaling defects discussed below are not due to a more
general deficiency of the bacteria to adhere to AGS cells. First, H.
pylori expressing the generated CagL point mutants exhibited sig-
nificant defects in injection and phosphorylation of CagA between
2 and 4 h of infection. Second, each of the CagL mutants in H.
pylori had significantly pronounced defects in activating the MAP
kinases ERK1/2 and serine phosphorylation of cortactin as well as
the induction of the AGS cell elongation phenotype during infec-
tion. This suggests that mutation of the RHS motif in H. pylori
results in various defects in the interaction of CagL with integrin
α5β1 with resulting inhibitory consequences for (i) the injection
of CagA and (ii) for the downstream signaling to ERK1/2 and
cortactin triggering cell elongation, especially at early times of
infection.
Taken together, our presented data provide evidence for a novel
domain in CagL playing a significant role in binding to integrin
α5β1 in vitro and for initiating signaling pathways through cer-
tain motifs encoded in the so-called RHS motif comprising the
FEANE sequence and its flanking amino acids.Wepropose that the
RGD motif is important for the CagL binding to integrins, while
subsequent binding of other integrin-specific CagL motifs may
assist in certain intracellular signaling events. Although we could
demonstrate that the RHS motif and its adjacent amino acids
are relevant in CagL–integrin interactions and have an impact
on the resulting signaling, more studies are necessary to further
define the specific amino acids relevant for integrin interaction
and downstream signaling. In addition, it has been shown that
besides CagL, multiple other H. pylori factors are also involved
in integrin β1 binding, including CagA, CagI, CagY, and possi-
bly CagH (Kwok et al., 2007; Jiménez-Soto et al., 2009; Shaffer
et al., 2011). Their individual role for integrin-targeting/binding
is not yet fully clear. Future studies should investigate whether
these proteins act together or at different stages of the infection
process.
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